一位90后小伙子正在准备走向纽交所。 2021年11月，Benching完成了1亿美元F轮融资，公司估值达61亿美元。此后，Benchling计划在2022年上市的消息便不绝于耳。 2012年，年仅22岁的Sajith Wickramasekara基于自身的研究经历，在麻省理工学院实验室中看到了商机：为科学家和 ...

Benchling AI debuts alongside major new capabilities for antibody discovery, automated data analysis, and development BOSTON, Oct. 14, 2025 /PRNewswire/ -- Benchling today unveiled major new ...

Launching with HighRes, Automata, Ginkgo Bioworks, Celltrio, Opentrons, and Hamilton, Benchling Automation brings an open ecosystem approach to lab-in-the-loop SAN FRANCISCO, May 28, 2026 /PRNewswire/ ...

Benchling AI debuts alongside major new capabilities for antibody discovery, automated data analysis, and development BOSTON, Oct. 14, 2025 /CNW/ -- Benchling today unveiled major new capabilities at ...

Investors are eager for the Benchling IPO. The company made headlines when it confidentially filed with the SEC to go public. Biotechnology is rewriting life as we know it. Our customers, spanning ...

Sajith Wickramasekara, Benchling’s CEO and co-founder. Eight months after enabling its R&D cloud to support FDA-regulated work done in later stages of biopharma product development, Benchling has ...

After collecting $300 million across two venture capital rounds last year, R&D cloud software developer Benchling is starting to spend some of that cash by making its first acquisition. The company ...